David Miller
Inversor de Capital Privado en Alpine Bioventures, GP, LLC .
Cargos activos de David Miller
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Inversor de Capital Privado | 01/09/2013 | - |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Corporate Officer/Principal | 01/04/2023 | - |
Historial de carrera de David Miller
Antiguos cargos conocidos de David Miller.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ALPINE IMMUNE SCIENCES, INC. | Inversor de Capital Privado | 01/01/2015 | 01/05/2019 |
ANGN BIOM | Corporate Officer/Principal | 01/05/2019 | - |
Biotech Stock Research LLC
Biotech Stock Research LLC Investment ManagersFinance Founded in 1999, Biotech Stock Research LLC, the parent of Biotech Monthly, is a research firm headquartered in Seattle, Washington. The firm conducts primary and secondary research on developmental-stage biotechnology companies. | Analyst-Equity | 01/01/2001 | - |
Director Ejecutivo | 01/01/1999 | - | |
Fundador | 23/11/2010 | - | |
Presidente | 01/01/2001 | - |
Formación de David Miller.
Western Washington University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
Analyst-Equity | 1 |
Sectorial
Health Technology | 4 |
Finance | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALPINE IMMUNE SCIENCES, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Biotech Stock Research LLC
Biotech Stock Research LLC Investment ManagersFinance Founded in 1999, Biotech Stock Research LLC, the parent of Biotech Monthly, is a research firm headquartered in Seattle, Washington. The firm conducts primary and secondary research on developmental-stage biotechnology companies. | Finance |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Finance |
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
Curevo, Inc.
Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Health Technology |
- Bolsa de valores
- Insiders
- David Miller
- Experiencia